Let’s talk

We are Synbionik, the emerging
European leader in Synthetic Biology

Synthetic Biology is the sustainable and potentially cost-efficient production of compounds through genetic engineering in microorganisms. We are building a new & superior Synthetic Biology operating system - unlocking the global impact of sustainable and cost-competitive production.

What we focus on

Synthetic Biology can do anything a plant can do

  • All organisms produce substances via a series of conversion steps in their cells
  • These conversion steps are facilitated by enzymes which in turn are encoded in the genome of an organism
  • Genetic manipulation allows us to make changes in the genome of organisms that introduce new enzymes and result in the production of desired compounds

What we focus on

Synthetic Biology can do anything a plant can do

  • All organisms produce substances via a series of conversion steps in their cells
  • These conversion steps are facilitated by enzymes which in turn are encoded in the genome of an organism
  • Genetic manipulation allows us to make changes in the genome of organisms that introduce new enzymes and result in the production of desired compounds

How we make a difference

We are developing a superior operating system for biosynthesis
using a novel, differentiated approach

Starting organism

Our starting organism combines many favorable and hard-to-induce characteristics for biosynthesis…

Conversion to superior operating system

We convert it via genetic engineering into a superior operating system vs. existing Synthetic Biology operating systems

Cheaper and more efficient production

Flexible basis for the production of various compounds that is available off-the-shelf

Novel IP, leading to protection vs. competition

Benefits of novel operating system:

  • Uniquely fast uptake of input
  • Extremely fast conversion in products
  • Ultra-efficient use of input
  • Robust and tolerant
  • Flexible towards a wide range of products
  • Significant reduction in production cost
  • Shorter development time and lower cost

What we offer

Custom fit technologies for every step of your process

With cutting-edge synthetic biology methodologies and equipment, we design smart organisms tailored to your needs. We constantly improve our bio-factories and processes to offer you solutions that fit your budget and that accelerate the time to market.

Microorganism design process

Our operating system allows the design and construction of microorganisms to manufacture a molecule from simple and low-cost substrates, thereby enabling cost-effective processes.

Phase 1

Evaluation & Legal Examination

Ideas, internal or based on customer inquiries, are evaluated with focus on the economic value and technical feasibility and freedom to operate.

Phase 2

Concept Development & Selection

Synbionik’s scientific units jointly develop efficient concepts for the manufacturing of the microorganism and / or natural substance. The research is supported by AI-based analyzes resulting in a selection of suitable computational methods to mine and select genetic building blocks which form the genetic vehicles that can be introduced into the microorganisms.

Phase 3

Construction & Optimization

Microorganisms are constructed and optimized in several iterative cycles by metabolic engineering in a multidisciplinary process and supported by innovative AI applications.

Phase 4

Cultivation & Analysis

For each new microorganism optimal cultivation and process conditions are developed. Cultivation systems of various scales enable to leverage growth and biosynthesis-related parameters. Precise, quantitative analysis methods and efficient product isolation procedures are established.

Phase 5

Upscaling & Commercialization

As soon as the microorganisms have been optimized for economic processes, the bioprocesses are scaled up in industrial plants (bioreactors) and commercialized. Synbionik provides ongoing support with the know-how gained in the process.

Process innovation

In contrast to whole cell bio catalysis, our operating system pursues a new and holistic approach based on very early precursors such as glucose. The host metabolism is linked to the newly introduced metabolic pathways.

Get to know us

Our Team

Leadership

Christoph Oldenburg,
Chief Executive Officer
(Managing Director)

Responsible for oversight of company and R&D activities

7+ years experiences in R&D and technology strategy in the biopharmaceutical industry Diploma (M.Sc. Equivalent) in Chemistry

Linus Willems,
Chief Commercial Officer
(Managing Director)

Prior Head of Investments at IONIQ Group (accompanied Synbionik right from the start)

B.Sc. Economics & Philosophy, M.Sc. in Management & Strategy